Lifetech Scientific Shares Rise Over 4% Intraday as Absorbable Peripheral Balloon-Expandable Stent Graft System Enters Innovation Medical Device Special Review Pathway

Stock News10-21

Hong Kong stock market movement: Lifetech Scientific (01302) rose more than 4% before noon. As of press time, it gained 4.08% to HK$1.53, with a turnover of HK$29.0531 million.

On the news front, Lifetech Scientific issued an announcement stating that the company received a formal written notice from the National Medical Products Administration, confirming that the ICS Elpis absorbable peripheral balloon-expandable stent graft system, independently developed by the company's subsidiary Yuanxin Technology (Shenzhen) Co., Ltd., has entered the National Medical Products Administration's special review procedure for innovative medical devices.

This product is suitable for the treatment of atherosclerotic stenosis or occlusive lesions of the common iliac artery and external iliac artery, and is the company's 20th product to enter this National Medical Products Administration procedure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment